21 Oct 2021
SAHPRA denies use of Sputnik V vaccine over concerns it may increase the risk of contracting HIV
By Staff Writer
SAHPRA is evaluating concerns over the safety of Sputnik V COVID-19 vaccine in populations at risk of HIV infection. The regulatory body has been engaged in a rolling review of the data for the vaccine since the initial application was submitted on 23 February 2021. This vaccine was developed by the Gamaleya Research Institute of...
